Ligation Devices Market size is expected to grow significantly from 2022 to 2028. This is considering the strong awareness about the benefits of tubal ligation procedures in female sterilization applications, and their ability to reduce the risks of ovarian cancer. In addition, the rising popularity of minimally invasive surgeries due to fewer complications and shorter hospital stay will further boost the demand for laparoscopic tubal ligation devices in the coming years. Ligation refers to the surgical process of tying up anatomical channels or the process of joining the chemical chains, such as those of protein or DNA. This process is used to treat various conditions like venous diseases through the surgical tying of veins by making a small incision into the skin to prevent blood pooling.
Significant increase in the obesity rate and the subsequent rise in the prevalence of hemorrhoids are some of the factors propelling the market trends through 2028. Hemorrhoids are highly common among obese individuals due to the excess body pressure that constricts the blood vessels around the anus and rectum, thus augmenting the need for rubber-band ligation and other procedures. Furthermore, the rapid technological advances and the production of innovative, smaller laparoscopic instruments will also contribute to overall market dynamics. However, potential side effects of tubal ligation surgery, including continued abdominal or pelvic pain, may hinder the market share during the forecast timeline.
With regards to application, the gastrointestinal disorders segment will account for an appreciable share in the market by 2028, driven by the growing incidences of conditions like angiodysplasia. As per TeachMeSurgery’s data, this common vascular abnormality of the GI tract is responsible for nearly 6% of the lower GI bleeding and over 8% of the upper GI bleeding. This factor, alongside the escalating usage of truncal vagotomy and suture ligation to treat upper GI bleeding among geriatric patients with hemorrhage and shock, will further amplify segment growth in the coming years.
Europe will emerge as a lucrative revenue pocket for the ligation devices market by 2028, as a result of the introduction of varied programs like EU4Health to strengthen the healthcare systems’ resilience in the region. According to the European Cancer Information System, colorectal cancer accounted for over 12.7% of the new cancer diagnoses in the EU-27 countries in 2020. These factors could stimulate the deployment of ligation devices in laparoscopic colorectal surgery over the foreseeable future.
B. Braun, GENICON, Olympus, Teleflex, Johnson & Johnson, Grena Limited, Medtronic, CooperSurgical, Conmed, and Applied Medical Resources are some of the key players operating in the market. These companies are focusing on various initiatives such as new device launches, mergers, and acquisitions to expand their business footprint in the competitive market.
Unprecedented impacts of the COVID-19 pandemic resulted in the decline of the number of elective surgeries such as tubal ligation in the initial phase of the crisis. As this type of surgery requires full anesthesia and intubation, it poses a greater risk of spreading the virus through droplets in the air. Situations such as these may have adversely affected the use of ligation devices in tubal ligation procedures in recent months. Despite these pandemic-induced disruptions, the development of gastrointestinal symptoms among coronavirus-infected patients may aid industry recovery in the coming years. A large group of critically ill patients manifests gastrointestinal complications, such as feeding intolerance to mesenteric ischemia, which could bolster the requirement of the ligation process for ischemia and other GI infections.
Market, By Product
Market, By Surgery
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: